Sort
23,748 grants matching “melanoma”
The PD-1/B7-H1 Pathway and Melanoma Immunity
$169,207Lieping Chen · Yale University · P50 · FY2013 · CA
scDECO: A novel statistical framework to identify differential co-expression gene combinations systematically using single-cell RNA sequencing data
$169,120Yen-Yi Ho · University Of South Carolina At Columbia · R21 · FY2022 · CA
CTLA4 as a guardian of the melanocyte stem cell immune privilege: Role in vitilligo
$169,119M. Raza Zaidi · Temple Univ Of The Commonwealth · R21 · FY2021 · AR
Combined ATRA and ipilimumab treatment to reduce immunosuppression in melanoma patients
$169,106Martin McCarter · University Of Colorado Denver · R21 · FY2016 · CA
Autophagy regulation of prostate tumor development
$169,106Andrew M Thorburn · University Of Colorado Denver · R21 · FY2017 · CA
Immunologic & Genetic Determinants of Outcome & Response to IFN-a2b Therapy
$169,083John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · CA
Molecular Genetics of Melanoma
$169,073Hensin Tsao · Massachusetts General Hospital · K24 · FY2019 · CA
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER
$169,039University Of Pittsburgh At Pittsburgh · P01 · FY2005 · CA
Epigenetic Regulation of Melanoma-Associated Fibroblast Plasticity
$169,000Dan Filipescu · Icahn School Of Medicine At Mount Sinai · R03 · FY2025 · CA
Targeting Gene Delivery to the CNS Blood-Brain Barrier
$168,984Irvin S.y. Chen · University Of California Los Angeles · R21 · FY2007 · NS
Immunologic & Genetic Determinants of Outcome & Response to IFN-a2b Therapy
$168,980John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA
Computer aided diagnosis of cancer metastases in the brain
$168,803Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2017 · LM
Pathology Core
$168,800David E E Elder · Wistar Institute · P01 · FY2012 · CA
Melanoma Biobank
$168,790Hensin Tsao · Massachusetts General Hospital · P01 · FY2017 · CA
Fluorescence molecular tomography to study T cell infiltration into tumors
$168,788Victor H. Engelhard · University Of Virginia · R21 · FY2015 · CA
A-to-I microRNA Editing and Melanoma Metastasis
$168,779Menashe Bareli · University Of Tx Md Anderson Can Ctr · R21 · FY2019 · CA
Co-operative roles for YAP1 and UCHL5 in cancer progression and therapy
$168,779Kunal Rai · University Of Tx Md Anderson Can Ctr · R21 · FY2019 · CA
Identification and Targeting of Chemotherapy Refractory Small Cell Lung Cancer
$168,779Afshin Dowlati · Case Western Reserve University · R21 · FY2019 · CA
Collateral Deletions Expose Targetable Metabolic Vulnerabilities in the PTEN locus
$168,779Florian Muller · University Of Tx Md Anderson Can Ctr · R21 · FY2019 · CA
In-vivo Confocal Spectropolarimetric Imaging
$168,778Arthur Lompado · Polaris Sensor Technologies, Inc. · R43 · FY2007 · CA
Sequencing Chr. 6 in Melanoma Patients
$168,750Jeremy S Edwards · University Of New Mexico · R21 · FY2009 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
$168,700Ashani T Weeraratna · Johns Hopkins University · R01 · FY2022 · CA
GFP-Reporter Constructs for Tumor Antigen Regulation
$168,700Cytocure, Llc · R43 · FY2002 · CA
Exploring IL-36gamma as a new tumor immune therapy
$168,699Binfeng Lu · University Of Pittsburgh At Pittsburgh · R21 · FY2017 · CA
Brain Cancer Zebrafish Xenotransplant Model for Drug Screening
$168,689Maryann L Haldi · Phylonix Pharmaceuticals, Inc. · R43 · FY2006 · NS